A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers.

TitleA comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers.
Publication TypeJournal Article
Year of Publication2011
AuthorsLevine, AJ, Palomo, M, Hinkin, CH, Valdes-Sueiras, M, Lopez, E, Mathisen, G, Donovan, S, Singer, EJ
JournalNeurobehav HIV Med
Volume3
Pagination79-86
Date Published2011
ISSN1179-1497
KeywordsInternal
Abstract

BACKGROUND: A substantial number of Spanish-speaking individuals from Mexico and Central America are now living in the United States. These individuals are at heightened risk for HIV infection and, due to late diagnosis and limited resources, for HIV-associated neurocognitive disorders (HAND). Early detection is key, yet adequate methods for detecting HAND in Spanish speakers, especially in resource-poor areas, remains problematic. Therefore, it is necessary to identify accurate yet efficient neurocognitive screening tools that are appropriate for use in resource-limited AIDS clinics serving Spanish-speaking patients.METHODS: Twenty-one Spanish-speaking, HIV-positive adults who migrated from Mexico or Central America underwent neuromedical and neurocognitive evaluation in Spanish. The concordance of three neurocognitive screening measures (the HIV Dementia Scale [HDS], the Mini-Mental State Examination [MMSE], and the NEUROPSI) with a comprehensive neuropsychological battery was examined. In addition, accuracy in detecting neurocognitive impairment using standard and alternative cutoff scores was examined.RESULTS: The HDS and the NEUROPSI showed high correlation with the comprehensive neuropsychological battery. The HDS and the NEUROPSI also had the highest sensitivity (67% and 75%, respectively) and specificity (50% and 38%, respectively). Both measures also showed greater sensitivity than the MMSE to very mild forms of HAND.CONCLUSION: In this small sample of HIV-positive Spanish speakers from Mexico and Central America living in the United States, the HDS and the NEUROPSI demonstrated reasonable accuracy in detecting neurocognitive impairment, while the MMSE demonstrated very poor accuracy. The HDS and the NEUROPSI were equally sensitive in detecting mild HAND. Continued test development is required to capture this disorder, especially in resource-limited settings.

DOI10.2147/NBHIV.S22553
Alternate JournalNeurobehav HIV Med
PubMed ID26448691
PubMed Central IDPMC4593057
Grant ListU01 MH083500 / MH / NIMH NIH HHS / United States
U24 MH100929 / MH / NIMH NIH HHS / United States